Perbedaan BFI Finance Indonesia Tbk dan Diagnos Laboratorium Utama Tbk.: BFI Finance Indonesia Tbk diperdagangkan di Rp785 (kapitalisasi pasar 12,03 T, volume 24 jam 12,2 jt), sedangkan Diagnos Laboratorium Utama Tbk. diperdagangkan di Rp220 (kapitalisasi pasar 310,75 M, volume 24 jam 159,2 rb). Perbedaan utamanya: BFI Finance Indonesia Tbk jauh lebih besar — sekitar 38,7× kapitalisasi pasar Diagnos Laboratorium Utama Tbk., dan BFI Finance Indonesia Tbk lebih aktif diperdagangkan (12,2 jt vs 159,2 rb). Mana yang lebih baik tergantung tujuan investasimu.
| BFIN | DGNS | |
|---|---|---|
Kapitalisasi Pasar | 12,03 T | 310,75 M |
Volume | 12,2 jt | 159,2 rb |
Lot | 122 rb | 1,59 rb |
Perputaran | 9,55 M | 34,72 jt |
Harga Rata-rata | 782,93 | 218,06 |
Nilai Transaksi | 9,55 M | 34,72 jt |
Harga Ekuilibrium Indikatif | 785 | 220 |
Volume Ekuilibrium Indikatif | 5,52 rb | 6 |
Imbal hasil berjalan pada periode standar
Berita terbaru kedua aset
PT BFI Finance Indonesia Tbk (the Company) formerly PT. Bunas Finance Indonesia Tbk (the Company) was established as PT Manufacturers Hanover Leasing Indonesia on April 7, 1982 based on Notarial deed No. 57 of Kartini Muljadi, S.H., Notary in Jakarta. Presently, the Company is engaged in leasing, consumer financing and factoring of accounts receivable. And changed to BFI Finance Indonesia on 2001
Selengkapnya di halaman BFIN →PT Diagnos Laboratorium Utama Tbk (the “Company”) was established in the Republic of Indonesia on August 29, 2007 under framework of the Domestic Capital Investment Law No. 6 Year 1968 based on Deed No.17 dated August 29, 2007, of Martinef, S.H., M.Si., Notary in Bekasi. The Company started its commercial operation in 2008.
Selengkapnya di halaman DGNS →